New data presented at Virtual EULAR 2021 Congress by AKL Research and Development demonstrate its investigational osteoarthritis drug APPA reduces senescence and reactive oxygen species production
Findings suggest APPA has a clear anti-inflammatory effect on human articular chondrocytes involved in osteoarthritis and reduces extracellular matrix degradation of cartilage STEVENAGE
Source: finanznachrichten.de